JEFFREY ROBBINS: Open Payments
NPI 1669408514 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,616 in 99 payments from 21 companies in 2025. Trend: 2023 $1,955 · 2024 $1,989 · 2025 $1,616
Food & beverage: $1,616
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $300 |
| PFIZER INC. | 14 | $175 |
| Antares Pharma, Inc. | 8 | $162 |
| AstraZeneca Pharmaceuticals LP | 7 | $159 |
| Novo Nordisk Inc | 8 | $139 |
| Corcept Therapeutics | 6 | $116 |
| Axsome Therapeutics, Inc. | 4 | $81 |
| Phathom Pharmaceuticals, Inc. | 7 | $76 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $69 |
| SHIELD THERAPEUTICS INC | 3 | $62 |
Products named: VRAYLAR, XYOSTED, NURTEC ODT, Korlym, Symbravo, BREZTRI, VOQUEZNA, CAPLYTA.
Industry payments across ID — which companies pay providers there.
